MediWound (NASDAQ: MDWD)
$18.65
(-1.0%)
-$0.19
Price as of May 3, 2024, 4:00 p.m. ET
MediWound Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
MediWound Company Info
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.